Characteristics of eligible trials.

CT, computed tomography; comp, comparative; d, day; diam, diameter; max, maximum; mm, millimeter; mo, month; multi, multicenter; MRI, magnetic resonance imaging; non–comp, non-comparative; non–rand, non-randomized; obs, observational; OCT LAR, intramuscular octreotide long-acting repeatable; OCT sc, octreotide subcutaneous; open, open-label; pts: patients; prosp, prospective; rand, randomized; retro, retrospective; RTX, radiotherapy; SSA, somatostatin analogs; single, single-center; SUR, surgery; TS, tumor shrinkage; unk, unknown; wk week.